Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine

References

• Remy CN. Metabolism of thiopyrimidines and thiopurines. S-Methylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissues. J Biol Chem. 1963;238:1078–1084. doi:10.1016/S0021-9258(18)81262-5
   PubMed Web of Science ®Google Scholar
• Cara CJ, Pena AS, Sans M, et al. Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice. Med Sci Monit. 2004;10(11):RA247–RA254.
   PubMed Web of Science ®Google Scholar
• Sahasranaman S, Howard D, Roy S. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol. 2008;64(8):753–767. doi:10.1007/s00228-008-0478-6
   PubMed Web of Science ®Google Scholar
• Karran P, Attard N. Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer. 2008;8(1):24–36. doi:10.1038/nrc2292
   PubMed Web of Science ®Google Scholar
• Relling MV, Gardner EE, Sandborn WJ, et al. Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther. 2013;93(4):324–325. doi:10.1038/clpt.2013.4
   PubMed Web of Science ®Google Scholar
• Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet. 1980;32(5):651–662.
   PubMed Web of Science ®Google Scholar
• Krynetski EY, Schuetz JD, Galpin AJ, Pui CH, Relling MV, Evans WE. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci U S A. 1995;92(4):949–953. doi:10.1073/pnas.92.4.949
   PubMed Web of Science ®Google Scholar
• Salavaggione OE, Wang L, Wiepert M, Yee VC, Weinshilboum RM. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics. Pharmacogenet Genomics. 2005;15(11):801–815. doi:10.1097/01.fpc.0000174788.69991.6b
   PubMed Web of Science ®Google Scholar
• Brouwer C, Marinaki AM, Lambooy LH, Duley JA, Shobowale-Bakre M, De Abreu RA. Pitfalls in the determination of mutant alleles of the thiopurine methyltransferase gene. Leukemia. 2001;15(11):1792–1793. doi:10.1038/sj.leu.2402285
   PubMed Web of Science ®Google Scholar
• Loennechen T, Yates CR, Fessing MY, Relling MV, Krynetski EY, Evans WE. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans. Clin Pharmacol Ther. 1998;64(1):46–51. doi:10.1016/S0009-9236(98)90021-2
   PubMed Web of Science ®Google Scholar
• Tai H-L, Krynetski EY, Yates CR, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet. 1996;58(4):694.
   PubMed Web of Science ®Google Scholar
• Otterness D, Szumlanski C, Lennard L, et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther. 1997;62(1):60–73. doi:10.1016/S0009-9236(97)90152-1
   PubMed Web of Science ®Google Scholar
• Isaza C, Henao J, Lopez AM, Cacabelos R. Allelic variants of the thiopurine methyltransferase (TPMT) gene in the Colombian population. Methods Find Exp Clin Pharmacol. 2003;25(6):423–429. doi:10.1358/mf.2003.25.6.769646
   PubMedGoogle Scholar
• Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics. 1999;9(1):37–42. doi:10.1097/00008571-199902000-00006
   PubMedGoogle Scholar
• Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, McLeod HL. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet. 1999;8(2):367–370. doi:10.1093/hmg/8.2.367
   PubMed Web of Science ®Google Scholar
• Chang JG, Lee LS, Chen CM, et al. Molecular analysis of thiopurine S-methyltransferase alleles in South-East Asian populations. Pharmacogenetics. 2002;12(3):191–195. doi:10.1097/00008571-200204000-00003
   PubMedGoogle Scholar
• Garrido C, Santizo VG, Mullers P, et al. Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia. Med Oncol. 2013;30(1):474. doi:10.1007/s12032-013-0474-2
   PubMed Web of Science ®Google Scholar
• Pratt VM, Cavallari LH, Fulmer ML, et al. TPMT and NUDT15 genotyping recommendations: a joint consensus recommendation of the association for molecular pathology, clinical pharmacogenetics implementation consortium, college of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase. J Mol Diagn. 2022;24(10):1051–1063. doi:10.1016/j.jmoldx.2022.06.007
   PubMed Web of Science ®Google Scholar
• Zimdahl Kahlin A, Helander S, Wennerstrand P, Vikingsson S, Martensson LG, Appell ML. Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism. Basic Clin Pharmacol Toxicol. 2021;128(1):52–65. doi:10.1111/bcpt.13483
   PubMed Web of Science ®Google Scholar
• Relling MV, Schwab M, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update. Clin Pharmacol Ther. 2019;105(5):1095–1105. doi:10.1002/cpt.1304
   PubMed Web of Science ®Google Scholar
• van den Bosch BJ, Coenen MJ, van den Bosch BJ. Pharmacogenetics of inflammatory bowel disease. Pharmacogenomics. 2021;22(1):55–66. doi:10.2217/pgs-2020-0095
   PubMed Web of Science ®Google Scholar
• Lee JM, Shim YJ, Kim DH, Jung N, Ha JS. The effect of NUDT15, TPMT, APEX1, and ITPA genetic variations on mercaptopurine treatment of pediatric acute lymphoblastic leukemia. Children. 2021;8(3):224. doi:10.3390/children8030224
   PubMedGoogle Scholar
• Ramos KN, Gregornik D, Ramos KS. Pharmacogenomics insights into precision pediatric oncology. Curr Opin Pediatr. 2021;33(6):564–569. doi:10.1097/MOP.0000000000001065
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Saito Y. Importance of NUDT15 polymorphisms in thiopurine treatments. J Pers Med. 2021;11(8):778. doi:10.3390/jpm11080778
   PubMed Web of Science ®Google Scholar
• Kakuta Y, Kinouchi Y, Shimosegawa T. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping. J Gastroenterol. 2018;53(2):172–180. doi:10.1007/s00535-017-1416-0
   PubMed Web of Science ®Google Scholar
• Yang JJ, Landier W, Yang W, et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol. 2015;33(11):1235–1242. doi:10.1200/JCO.2014.59.4671
   PubMed Web of Science ®Google Scholar
• Miao Q, Yan L, Zhou Y, et al. Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest China patients with autoimmune hepatitis. Sci Rep. 2021;11(1):7984. doi:10.1038/s41598-021-87095-0
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lauschke VM. Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health. Hum Genet. 2022;141(6):1113–1136. doi:10.1007/s00439-021-02385-x
   PubMed Web of Science ®Google Scholar
• Eltantawy N, El-Zayyadi IAE-H, Elberry AA, et al. Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients. Beni-Suef Univ J Basic Appl Sci. 2023;12(1):14. doi:10.1186/s43088-023-00340-5
   Google Scholar
• Suarez-Kurtz G, de Araujo GS. Pharmacogenetic differentiation across Latin America. Pharmacogenomics. 2022;23(4):225–233. doi:10.2217/pgs-2021-0152
   PubMed Web of Science ®Google Scholar
• Suarez-Kurtz G, Parra EJ. Population diversity in pharmacogenetics: a Latin American perspective. Adv Pharmacol. 2018;83:133–154.
   PubMedGoogle Scholar
• Zambrano AK, Gaviria A, Cobos-Navarrete S, et al. The three-hybrid genetic composition of an Ecuadorian population using AIMs-InDels compared with autosomes, mitochondrial DNA and Y chromosome data. Sci Rep. 2019;9(1):9247. doi:10.1038/s41598-019-45723-w
   PubMedGoogle Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. doi:10.1093/nar/16.3.1215
   PubMed Web of Science ®Google Scholar
• Pereira R, Phillips C, Pinto N, et al. Straightforward inference of ancestry and admixture proportions through ancestry-informative insertion deletion multiplexing. PLoS One. 2012;7(1):e29684. doi:10.1371/journal.pone.0029684
   PubMed Web of Science ®Google Scholar
• Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155(2):945–959. doi:10.1093/genetics/155.2.945
   PubMed Web of Science ®Google Scholar
• Larovere LE, de Kremer RD, Lambooy LH, De Abreu RA, de Kremer RD. Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Ann Clin Biochem. 2003;40(4):388–393. doi:10.1258/000456303766477039
   PubMedGoogle Scholar
• Boson WL, Romano-Silva MA, Correa H, Falcao RP, Teixeira-Vidigal PV, De Marco L. Thiopurine methyltransferase polymorphisms in a Brazilian population. Pharmacogenomics J. 2003;3(3):178–182. doi:10.1038/sj.tpj.6500175
   PubMed Web of Science ®Google Scholar
• Lu HF, Shih MC, Hsueh SC, Chen CM, Chang JY, Chang JG. Molecular analysis of the thiopurine S-methyltransferase alleles in Bolivians and Tibetans. J Clin Pharm Ther. 2005;30(5):491–496. doi:10.1111/j.1365-2710.2005.00640_1.x
   PubMed Web of Science ®Google Scholar
• Garat A, Cauffiez C, Renault N, et al. Characterisation of novel defective thiopurine S-methyltransferase allelic variants. Biochem Pharmacol. 2008;76(3):404–415. doi:10.1016/j.bcp.2008.05.009
   PubMed Web of Science ®Google Scholar
• Jimenez-Morales S, Ramirez-Florencio M, Mejia-Arangure JM, et al. Analysis of thiopurine S-Methyltransferase deficient alleles in acute lymphoblastic leukemia patients in Mexican patients. Arch Med Res. 2016;47(8):615–622. doi:10.1016/j.arcmed.2016.11.018
   PubMed Web of Science ®Google Scholar
• Haglund S, Lindqvist M, Almer S, Peterson C, Taipalensuu J. Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin Chem. 2004;50(2):288–295. doi:10.1373/clinchem.2003.023846
   PubMed Web of Science ®Google Scholar
• Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics. 2004;14(7):407–417. doi:10.1097/01.fpc.0000114745.08559.db
   PubMedGoogle Scholar
• Rossi AM, Bianchi M, Guarnieri C, Barale R, Pacifici GM. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol. 2001;57(1):51–54. doi:10.1007/s002280000246
   PubMed Web of Science ®Google Scholar
• Kurzawski M, Gawronska-Szklarz B, Drozdzik M. Frequency distribution of thiopurine S-methyltransferase alleles in a Polish population. Ther Drug Monit. 2004;26(5):541–545. doi:10.1097/00007691-200410000-00013
   PubMed Web of Science ®Google Scholar
• Indjova D, Atanasova S, Shipkova M, Armstrong VW, Oellerich M, Svinarov D. Phenotypic and genotypic analysis of thiopurine s-methyltransferase polymorphism in the Bulgarian population. Ther Drug Monit. 2003;25(5):631–636. doi:10.1097/00007691-200310000-00013
   PubMed Web of Science ®Google Scholar
• Loennechen T, Utsi E, Hartz I, Lysaa R, Kildalsen H, Aarbakke J. Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway. Clin Pharmacol Ther. 2001;70(2):183–188. doi:10.1067/mcp.2001.117445
   PubMed Web of Science ®Google Scholar
• Zhang JP, Guan YY, Wu JH, Jiang WQ, Huang M. Genetic polymorphism of the thiopurine S-methyltransferase of healthy Han Chinese. Ai Zheng. 2003;22(4):385–388.
   PubMedGoogle Scholar
• Kham SK, Tan PL, Tay AH, Heng CK, Yeoh AE, Quah TC. Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2002;24(5):353–359. doi:10.1097/00043426-200206000-00006
   PubMed Web of Science ®Google Scholar
• Srimartpirom S, Tassaneeyakul W, Kukongviriyapan V, Tassaneeyakul W. Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Br J Clin Pharmacol. 2004;58(1):66–70. doi:10.1111/j.1365-2125.2004.02112.x
   PubMed Web of Science ®Google Scholar
• Kubota T, Chiba K. Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus. Br J Clin Pharmacol. 2001;51(5):475–477. doi:10.1046/j.1365-2125.2001.01371.x
   PubMed Web of Science ®Google Scholar
• Tumer TB, Ulusoy G, Adali O, Sahin G, Gozdasoglu S, Arinc E. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia. Am J Hematol. 2007;82(10):906–910. doi:10.1002/ajh.20947
   PubMed Web of Science ®Google Scholar
• Moini M, Ghaderi F, Sagheb MM, et al. The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population. Mol Biol Rep. 2012;39(4):4581–4587. doi:10.1007/s11033-011-1248-6
   PubMed Web of Science ®Google Scholar
• McLeod HL, Pritchard SC, Githang’a J, et al. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics. 1999;9(6):773–776. doi:10.1097/00008571-199912000-00012
   PubMedGoogle Scholar
• Hamdy SI, Hiratsuka M, Narahara K, et al. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol. 2003;55(6):560–569. doi:10.1046/j.1365-2125.2003.01786.x
   PubMed Web of Science ®Google Scholar
• Oliveira E, Quental S, Alves S, Amorim A, Prata MJ. Do the distribution patterns of polymorphisms at the thiopurine S-methyltransferase locus in sub-Saharan populations need revision? Hints from Cabinda and Mozambique. Eur J Clin Pharmacol. 2007;63(7):703–706. doi:10.1007/s00228-007-0310-8
   PubMed Web of Science ®Google Scholar
• Saxena S, Krishna Murthy TP, Chandrashekhar CR, et al. A bioinformatics approach to the identification of novel deleterious mutations of human TPMT through validated screening and molecular dynamics. Sci Rep. 2022;12(1):18872. doi:10.1038/s41598-022-23488-z
   PubMed Web of Science ®Google Scholar
• Flores-Espinoza R, Angulo-Pozo A, Garzón-Salazar A, et al. Evaluating population structure of Ecuador for forensic STR markers. Forensic Sci Int Genet Suppl Ser. 2022;8:102–104. doi:10.1016/j.fsigss.2022.09.036
   Web of Science ®Google Scholar
• Flores-Espinoza R, Paz-Cruz E, Ruiz-Pozo VA, et al. Investigating genetic diversity in admixed populations from Ecuador. Am J Phys Anthropol. 2021;176(1):109–119. doi:10.1002/ajpa.24341
   PubMed Web of Science ®Google Scholar
• Bryc K, Velez C, Karafet T, et al. Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci U S A. 2010;107(Suppl 2):8954–8961. doi:10.1073/pnas.0914618107
   PubMed Web of Science ®Google Scholar
• Bedoya CA, Dreisigacker S, Hearne S, et al. Genetic diversity and population structure of native maize populations in Latin America and the Caribbean. PLoS One. 2017;12(4):e0173488. doi:10.1371/journal.pone.0173488
   PubMed Web of Science ®Google Scholar
• Zambrano A, Gaviria A, Vela M, et al. Ancestry characterization of ecuador’s highland mestizo population using autosomal AIM-INDELs. Forensic Sci Int Genet Suppl Ser. 2017;6:e477–e478. doi:10.1016/j.fsigss.2017.09.191
   Google Scholar
• Nagar SD, Conley AB, Chande AT, et al. Genetic ancestry and ethnic identity in Ecuador. HGG Adv. 2021;2(4):100050. doi:10.1016/j.xhgg.2021.100050
   PubMedGoogle Scholar
• Appell ML, Berg J, Duley J, et al. Nomenclature for alleles of the thiopurine methyltransferase gene. Pharmacogenet Genomics. 2013;23(4):242–248. doi:10.1097/FPC.0b013e32835f1cc0
   PubMed Web of Science ®Google Scholar
• YPH I, Helander S, Kahlin AZ, et al. One amino acid makes a difference-characterization of a new TPMT allele and the influence of SAM on TPMT stability. Sci Rep. 2017;7:46428. doi:10.1038/srep46428
   PubMed Web of Science ®Google Scholar
• Zhou Y, Dagli Hernandez C, Lauschke VM. Population-scale predictions of DPD and TPMT phenotypes using a quantitative pharmacogene-specific ensemble classifier. Br J Cancer. 2020;123(12):1782–1789. doi:10.1038/s41416-020-01084-0
   PubMed Web of Science ®Google Scholar
• Tamm R, Oselin K, Kallassalu K, et al. Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population. Clin Chem Lab Med. 2008;46(7):974–979. doi:10.1515/CCLM.2008.187
   PubMed Web of Science ®Google Scholar
• Marinaki AM, Arenas M, Khan ZH, et al. Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians. Pharmacogenetics. 2003;13(2):97–105. doi:10.1097/00008571-200302000-00006
   PubMedGoogle Scholar
• Lopez-Cortes A, Guerrero S, Redal MA, Alvarado AT, Quinones LA. State of art of cancer pharmacogenomics in Latin American populations. Int J Mol Sci. 2017;18(6):639. doi:10.3390/ijms18060639
   PubMed Web of Science ®Google Scholar
• Burgos G, Gomes V, Nguidi M, et al. Genetic ancestry in afro-descendants from the Andes and Pacific coast regions of Ecuador. Forensic Sci Int Genet Suppl Ser. 2022;8:254–256. doi:10.1016/j.fsigss.2022.10.053
   Web of Science ®Google Scholar
• Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet. 1999;8(2):371–376. doi:10.1093/hmg/8.2.371
   PubMed Web of Science ®Google Scholar
• Suarez-Kurtz G, Araujo GS, de Sousa SJ. Pharmacogenomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing. Pharmacogenet Genomics. 2020;30(1):1–4. doi:10.1097/FPC.0000000000000388
   PubMed Web of Science ®Google Scholar
• Texis T, Guzman-Cruz C, Rodriguez-Dorantes M, Sanchez-Garcia S, Mino-Leon D, Gonzalez-Covarrubias V. Genotyping NUDT15*3 rs1166855232 reveals higher frequency of potential adverse effects of thiopurines in Natives and Mestizos from Mexico. Pharmacol Rep. 2022;74(1):257–262. doi:10.1007/s43440-021-00287-3
   PubMed Web of Science ®Google Scholar
• Lopez-Cortes A, Esperon P, Martinez MF, et al. Editorial: pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II. Front Pharmacol. 2023;14:1211712. doi:10.3389/fphar.2023.1211712
   PubMed Web of Science ®Google Scholar
• Katara P, Kuntal H. TPMT polymorphism: when shield becomes weakness. Interdiscip Sci. 2016;8(2):150–155. doi:10.1007/s12539-015-0111-1
   PubMed Web of Science ®Google Scholar
• Stocco G, Martelossi S, Barabino A, et al. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease. Dig Liver Dis. 2005;37(12):940–945. doi:10.1016/j.dld.2005.08.003
   PubMedGoogle Scholar
• Lennard L. TPMT in the treatment of Crohn’s disease with azathioprine. Gut. 2002;51(2):143–146. doi:10.1136/gut.51.2.143
   PubMed Web of Science ®Google Scholar
• Nguyen CM, Mendes MA, Ma JD. Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk. PLoS Curr. 2011;3:RRN1236. doi:10.1371/currents.RRN1236
   PubMedGoogle Scholar
• Stanulla M, Schaeffeler E, Flohr T, et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA. 2005;293(12):1485–1489. doi:10.1001/jama.293.12.1485
   PubMed Web of Science ®Google Scholar
• McLeod HL, Krynetski EY, Relling MV, Evans WE. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia. 2000;14(4):567–572. doi:10.1038/sj.leu.2401723
   PubMed Web of Science ®Google Scholar
• Jena A, Jha DK, Kumar MP, et al. Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis. Expert Rev Clin Pharmacol. 2021;14(4):491–501. doi:10.1080/17512433.2021.1900729
   PubMed Web of Science ®Google Scholar
• Schwarz UI, Woldanski-Travaglini M, Swanston V, et al. Thiopurine methyltransferase intermediate metabolizer status and thiopurine-associated toxicity during maintenance therapy in childhood acute lymphoblastic leukemia. Clin Pharmacol Ther. 2023;113(6):1326–1336. doi:10.1002/cpt.2894
   PubMed Web of Science ®Google Scholar
• Lennard L. Implementation of TPMT testing. Br J Clin Pharmacol. 2014;77(4):704–714. doi:10.1111/bcp.12226
   PubMed Web of Science ®Google Scholar
• Conneely SE, Cooper SL, Rau RE. Use of allopurinol to mitigate 6-mercaptopurine associated gastrointestinal toxicity in acute lymphoblastic leukemia. Front Oncol. 2020;10:1129. doi:10.3389/fonc.2020.01129
   PubMed Web of Science ®Google Scholar
• Almoguera B, Vazquez L, Connolly JJ, et al. Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes. Front Genet. 2014;5:96. doi:10.3389/fgene.2014.00096
   PubMed Web of Science ®Google Scholar